Sort by
Refine Your Search
-
Listed
-
Category
-
Employer
- Institute for bioengineering of Catalonia, IBEC
- ICN2
- Centre for Genomic Regulation
- Centro de Biotecnología y Genómica de Plantas, CBGP (UPM-INIA)
- Consejo Superior de Investigaciones Cientificas
- FUNDACIO INSTITU DE RECERCA EN ENERGIA DE CATALUNYA
- FUNDACION DE INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE
- Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron (VHIO)
- ISGLOBAL
- Institut Català de Nanociència i Nanotecnologia
- Institut Català de Paleontologia Miquel Crusafont
- Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)
- Integra Therapeutics
- UNIVERSIDAD POLITECNICA DE MADRID
- UNIVERSIDAD PUBLICA DE NAVARRA
- Universidad Nebrija
- Universidad de Alicante
- Universitat Pompeu Fabra
- University of the Basque Country UPV/EHU
- 9 more »
- « less
-
Field
-
closed. Final scores will be modulated by the results of an interview and career duration. A. Research outputs: 15% B. International visibility & mobility: 5% C. Fundraising abilities: 5% D. Supervision
-
: prepare research findings for publication in academic journals and present at conferences and public forums. Collaboration: work with interdisciplinary teams including scientists, educators, and community
-
. The candidate will employ a range of in vitro and in vivo models, including genetically engineered cell lines, humanized mouse models, and syngeneic systems, to validate candidate genes and investigate
-
Fundació Privada Institut d'Investigació Oncològica de Vall d'Hebron (VHIO) | Spain | about 1 month ago
Maus* et al, Immunity, 2017). 3. Metabolic senescence of cells (Maus et al., Cell Metabolism, 2017) contribute to cancer. The lab works with mouse models, in vitro models, and with human specimen
-
career. The ICN2 actively promotes international and interdisciplinary research. As such, our PhD students are strongly encouraged to undertake mobility actions, like research visits abroad (including